Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • NewsRegulatory

City of Hope Honors Tom Corson with Michael Bublé Performance and Cher Appearance

  • The Pharma Data
  • October 16, 2025

Music Industry Icons Unite to Celebrate Tom Corson at City of Hope’s Spirit of Life Gala, Raising Funds to Advance Cancer Research, Survivorship Programs, and Integrative Therapies one of the…

Read MoreCity of Hope Honors Tom Corson with Michael Bublé Performance and Cher Appearance
  • Press Releases

TP et l’UNICEF Renouvellement de Partenariat Humanitaire

  • The Pharma Data
  • October 16, 2025

TP and UNICEF Renew Partnership to Advance Education and Humanitarian Support Globally TP (formerly Teleperformance), a global leader in enterprise digital solutions, and UNICEF have announced the renewal of their…

Read MoreTP et l’UNICEF Renouvellement de Partenariat Humanitaire
  • News

SelectQuote Research Reveals Critical Gaps in Healthcare, Urges Personalized Solutions

  • The Pharma Data
  • October 16, 2025

SelectQuote Research Reveals Critical Gaps in Medicare Care, Underscoring Need for Personalized Healthcare Solutions OVERLAND PARK, Kan.–(BUSINESS WIRE)–SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and the…

Read MoreSelectQuote Research Reveals Critical Gaps in Healthcare, Urges Personalized Solutions
  • Research

Viatris Acquires Aculys Pharma, Securing Pitolisant and Spydia® Rights in Japan & Asia-Pacific

  • The Pharma Data
  • October 16, 2025

Viatris Expands CNS Portfolio in Japan with Acquisition of Aculys Pharma, Gaining Exclusive Rights to Pitolisant and Spydia® Viatris Inc. (Nasdaq: VTRS), a leading global healthcare company, today announced the…

Read MoreViatris Acquires Aculys Pharma, Securing Pitolisant and Spydia® Rights in Japan & Asia-Pacific
  • Business

WuXi Biologics Celebrates Sonoma Biotherapeutics’ Fred Ramsdell, PhD, 2025 Nobel Laureate

  • The Pharma Data
  • October 16, 2025

Transforming Autoimmune and Inflammatory Disease Therapies WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), proudly congratulates Dr. Fred Ramsdell, PhD, co-founder and Chair of the…

Read MoreWuXi Biologics Celebrates Sonoma Biotherapeutics’ Fred Ramsdell, PhD, 2025 Nobel Laureate
  • Press Releases

Taiho Pharma Licenses PI3Kα Inhibitor Risovalisib (CYH33) to Haihe Biopharma

  • The Pharma Data
  • October 16, 2025

Taiho Pharmaceutical Grants Exclusive Rights for PI3Kα Inhibitor Risovalisib (CYH33) to Haihe Biopharma Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an…

Read MoreTaiho Pharma Licenses PI3Kα Inhibitor Risovalisib (CYH33) to Haihe Biopharma
  • Research

argenx to Showcase Immunology Advances at 2025 AANEM and MGFA Meetings

  • The Pharma Data
  • October 16, 2025

argenx to Present Comprehensive Immunology Data at 2025 AANEM Annual Meeting and MGFA Scientific Session argenx SE (Euronext & Nasdaq: ARGX), a global immunology company dedicated to improving the lives…

Read Moreargenx to Showcase Immunology Advances at 2025 AANEM and MGFA Meetings
  • Regulatory

CLARITY Study: 90% Prefer Long-Acting Cabotegravir Over Lenacapavir for HIV

  • The Pharma Data
  • October 16, 2025

ViiV Healthcare CLARITY Study Shows Cabotegravir Long-Acting Injections More Acceptable and Preferred Over Lenacapavir GSK plc (LSE/NYSE: GSK) announced today that ViiV Healthcare, the global specialist HIV company majority owned…

Read MoreCLARITY Study: 90% Prefer Long-Acting Cabotegravir Over Lenacapavir for HIV
  • BusinessPress Releases

Zoetis Receives Health Canada Approval for Lenivia® to Treat Osteoarthritis Pain in Dogs

  • The Pharma Data
  • October 16, 2025

Zoetis Receives Health Canada Approval for Lenivia® to Relieve Osteoarthritis Pain in Dogs Zoetis Inc. today announced that Health Canada has approved Lenivia® (izenivetmab injection) for the treatment of pain…

Read MoreZoetis Receives Health Canada Approval for Lenivia® to Treat Osteoarthritis Pain in Dogs
  • News

Regeneron Highlights Oncology Pipeline Progress at ESMO 2025

  • The Pharma Data
  • October 16, 2025

Regeneron Unveils Key Oncology Pipeline Updates at ESMO 2025, Highlighting Patient-Centric Approaches for Hard-to-Treat Cancers Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that new and updated data from its oncology…

Read MoreRegeneron Highlights Oncology Pipeline Progress at ESMO 2025
  • Press ReleasesRegulatory

CVS Pharmacy Finalizes Nationwide Acquisition of Rite Aid Assets

  • The Pharma Data
  • October 16, 2025

CVS Pharmacy Finalizes Nationwide Acquisition of Rite Aid and Bartell Drugs Assets, Expanding Access to Care Across the U.S. CVS Pharmacy, a subsidiary of CVS Health, today announced the successful…

Read MoreCVS Pharmacy Finalizes Nationwide Acquisition of Rite Aid Assets
  • Research

Sanofi Establishes Global Autoimmune Research Hub in Montpellier

  • The Pharma Data
  • October 16, 2025

Sanofi Establishes Montpellier as the Global Hub for Translational Research in Autoimmune Diseases Sanofi has announced the launch of a Translational Center of Excellence in Montpellier, a first-of-its-kind initiative developed…

Read MoreSanofi Establishes Global Autoimmune Research Hub in Montpellier
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • CareDx to Present Over 50 Abstracts, Including 16 Oral Sessions, at ISHLT 46th Annual Meeting
  • FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) Regimen
  • Pfizer Highlights Oncology Innovations and Next-Generation Pipeline at ASCO 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.